BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6247214)

  • 21. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Endorphin and met-enkephalins: their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control.
    Dupont A; Barden N; Cusan L; Mérand Y; Labrie F; Vaudry H
    Fed Proc; 1980 Jun; 39(8):2544-50. PubMed ID: 7380027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of peripheral adrenergic neurotransmission by methionine-enkephalin.
    Gaddis RR; Dixon WR
    J Pharmacol Exp Ther; 1982 May; 221(2):282-8. PubMed ID: 6281410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiological effects of opiates and endogenous peptides on central neurons].
    Davies J
    Ann Anesthesiol Fr; 1978; 19(5):399-405. PubMed ID: 29535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mu-selective opioid peptides stimulate prolactin release in lactating rats.
    Baumann MH; Rabii J
    J Neuroendocrinol; 1990 Jun; 2(3):271-6. PubMed ID: 19215346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors.
    Westfall TC; Grant H; Naes L; Meldrum M
    Eur J Pharmacol; 1983 Aug; 92(1-2):35-42. PubMed ID: 6628536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological differentiation of presynaptic inhibitory alpha-adrenoceptors and opiate receptors in the cat nictitating membrane.
    Dubocovich ML; Langer SZ
    Br J Pharmacol; 1980 Nov; 70(3):383-93. PubMed ID: 6254597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of blockade of the dopamine, serotonin and cholinergic receptors on opioid modification of habituation in the visual cortex of the turtle].
    Pivovarov AS; Izmest'ev VI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(6):1099-109. PubMed ID: 2834891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of morphine, naloxone and an enkephalin analogue on plasma prolactin, growth hormone, insulin and thyroxine in goats [proceedings].
    Hart IC; Cowie AT
    J Endocrinol; 1978 May; 77(2):16P-17P. PubMed ID: 660036
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition by cholinergic agonists of the prolactin release induced by morphine.
    Muraki T; Tokunaga Y; Nakadate T; Kato R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):249-54. PubMed ID: 503252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
    Gold MS; Redmond DE; Donabedian RK
    Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine can stimulate prolactin release independent of a dopaminergic mechanism.
    Shin SH; Obonsawin MC; Van Vugt DA; Baby N; Jhamandas K
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1381-5. PubMed ID: 2907416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of two enkephalin analogues, morphine sulphate, dopamine and naloxone on prolactin secretion from rat anterior pituitary glands in vitro.
    Bentley AM; Wallis M
    J Endocrinol; 1986 Jun; 109(3):313-20. PubMed ID: 3734666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiates act centrally on GH and PRL release.
    Panerai AE; Casanueva F; Martini A; Mantegazza P; Di Giulio AM
    Endocrinology; 1981 Jun; 108(6):2400-2. PubMed ID: 7227313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interference of naloxone hydrochloride in the teratogenic activity of opiates.
    Jurand A
    Teratology; 1985 Apr; 31(2):235-40. PubMed ID: 2986307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat.
    Idänpään-Heikkilä JJ; Rauhala P; Männistö PT
    Pharmacol Toxicol; 1996 Mar; 78(3):136-42. PubMed ID: 8882345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone.
    Vargish T; Beamer KC; Daly T; Riggs TR
    Circ Shock; 1987; 23(3):189-95. PubMed ID: 2827907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.